Evidence map›Paper›PMID 41644964›Full record

ArticleScientific reports2026

Efficient and sustainable nanocatalyst based on dithiocarbamate ionic liquid functionalized magnetic graphene oxide for green synthesis of 1,4-dihydropyridins.

Reza Ghorbannia, Robabeh Baharfar, Behrooz Maleki

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Reza GhorbanniaDepartment of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, 47416-95447, Iran.
Robabeh BaharfarDepartment of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, 47416-95447, Iran. baharfar@umz.ac.ir.
Behrooz MalekiDepartment of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, 47416-95447, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of catalytic systems that simultaneously achieve high activity, durability, and recyclability remains a central challenge in green and sustainable chemistry. To address the inherent limitations of conventional homogeneous and heterogeneous catalysts, we report a multifunctional nanocatalyst comprising dithiocarbamate-functionalized ionic liquids supported on magnetic graphene oxide (MGO-IL-DTC). In this architecture, magnetic graphene oxide provides a high surface area and facile magnetic recovery, ionic liquids create tunable ionic microenvironments, and dithiocarbamate moieties introduce electron-rich coordination sites. The synergistic interplay of these components affords superior catalytic activity, remarkable stability, and straightforward reusability. The catalyst structure was confirmed using Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), elemental analysis, vibrating sample magnetometer (VSM), scanning electron microscopy (SEM), X-ray diffraction (XRD), energy dispersive spectroscopy (EDS), and EDS mapping. The nanocatalyst efficiently promoted the synthesis of 1,4-dihydropyridine (1,4-DHP) derivatives from aromatic aldehydes, dimedone, β-ketoesters, and ammonium acetate in ethanol under mild conditions, affording high yields (85–95%) within 10–15 min. Moreover, the catalyst could be magnetically recovered and reused for at least five consecutive cycles without appreciable loss of activity. These findings highlight MGO-IL-DTC as a robust and modular platform for sustainable catalytic applications, aligning with the principles of green chemistry.

Indexed as

1,4-DihydropyridinesHeterogeneous catalystsIonic liquidsMagnetic graphene oxide

Identifiers

PMID41644964
PMCPMC12932863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.